249 related articles for article (PubMed ID: 29572492)
21. Prediction of IDH1 Mutation Status in Glioblastoma Using Machine Learning Technique Based on Quantitative Radiomic Data.
Lee MH; Kim J; Kim ST; Shin HM; You HJ; Choi JW; Seol HJ; Nam DH; Lee JI; Kong DS
World Neurosurg; 2019 May; 125():e688-e696. PubMed ID: 30735871
[TBL] [Abstract][Full Text] [Related]
22. Sexually dimorphic radiogenomic models identify distinct imaging and biological pathways that are prognostic of overall survival in glioblastoma.
Beig N; Singh S; Bera K; Prasanna P; Singh G; Chen J; Saeed Bamashmos A; Barnett A; Hunter K; Statsevych V; Hill VB; Varadan V; Madabhushi A; Ahluwalia MS; Tiwari P
Neuro Oncol; 2021 Feb; 23(2):251-263. PubMed ID: 33068415
[TBL] [Abstract][Full Text] [Related]
23. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.
Weller M; Felsberg J; Hartmann C; Berger H; Steinbach JP; Schramm J; Westphal M; Schackert G; Simon M; Tonn JC; Heese O; Krex D; Nikkhah G; Pietsch T; Wiestler O; Reifenberger G; von Deimling A; Loeffler M
J Clin Oncol; 2009 Dec; 27(34):5743-50. PubMed ID: 19805672
[TBL] [Abstract][Full Text] [Related]
24. The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma.
Liu X; Mangla R; Tian W; Qiu X; Li D; Walter KA; Ekholm S; Johnson MD
J Neurooncol; 2017 Dec; 135(3):553-560. PubMed ID: 28889246
[TBL] [Abstract][Full Text] [Related]
25. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S
J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347
[TBL] [Abstract][Full Text] [Related]
26. Multivariate Analysis of Preoperative Magnetic Resonance Imaging Reveals Transcriptomic Classification of
Rathore S; Akbari H; Bakas S; Pisapia JM; Shukla G; Rudie JD; Da X; Davuluri RV; Dahmane N; O'Rourke DM; Davatzikos C
Front Comput Neurosci; 2019; 13():81. PubMed ID: 31920606
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Molecular and Imaging Biomarkers in Primary Glioblastoma.
Bosnyák E; Michelhaugh SK; Klinger NV; Kamson DO; Barger GR; Mittal S; Juhász C
Clin Nucl Med; 2017 May; 42(5):341-347. PubMed ID: 28195901
[TBL] [Abstract][Full Text] [Related]
28. Correlation Between Tumor Location and Clinical Properties of Glioblastomas in Frontal and Temporal Lobes.
Li HY; Sun CR; He M; Yin LC; Du HG; Zhang JM
World Neurosurg; 2018 Apr; 112():e407-e414. PubMed ID: 29355809
[TBL] [Abstract][Full Text] [Related]
29. Early postoperative tumor progression predicts clinical outcome in glioblastoma-implication for clinical trials.
Merkel A; Soeldner D; Wendl C; Urkan D; Kuramatsu JB; Seliger C; Proescholdt M; Eyupoglu IY; Hau P; Uhl M
J Neurooncol; 2017 Apr; 132(2):249-254. PubMed ID: 28101701
[TBL] [Abstract][Full Text] [Related]
30. Glioblastoma: Vascular Habitats Detected at Preoperative Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging Predict Survival.
Juan-Albarracín J; Fuster-Garcia E; Pérez-Girbés A; Aparici-Robles F; Alberich-Bayarri Á; Revert-Ventura A; Martí-Bonmatí L; García-Gómez JM
Radiology; 2018 Jun; 287(3):944-954. PubMed ID: 29357274
[TBL] [Abstract][Full Text] [Related]
31. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
[TBL] [Abstract][Full Text] [Related]
32. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
33. Frontal glioblastoma multiforme may be biologically distinct from non-frontal and multilobar tumors.
Paldor I; Pearce FC; Drummond KJ; Kaye AH
J Clin Neurosci; 2016 Dec; 34():128-132. PubMed ID: 27593971
[TBL] [Abstract][Full Text] [Related]
34. Higher vascularity at infiltrated peripheral edema differentiates proneural glioblastoma subtype.
Chelebian E; Fuster-Garcia E; Álvarez-Torres MDM; Juan-Albarracín J; García-Gómez JM
PLoS One; 2020; 15(10):e0232500. PubMed ID: 33052913
[TBL] [Abstract][Full Text] [Related]
35. Imaging phenotypes from MRI for the prediction of glioma immune subtypes from RNA sequencing: A multicenter study.
Duan J; Zhang Z; Chen Y; Zhao Y; Sun Q; Wang W; Zheng H; Liang D; Cheng J; Yan J; Li ZC
Mol Oncol; 2023 Apr; 17(4):629-646. PubMed ID: 36688633
[TBL] [Abstract][Full Text] [Related]
36. Morphologic patterns of noncontrast-enhancing tumor in glioblastoma correlate with IDH1 mutation status and patient survival.
Lasocki A; Gaillard F; Tacey M; Drummond K; Stuckey S
J Clin Neurosci; 2018 Jan; 47():168-173. PubMed ID: 28988652
[TBL] [Abstract][Full Text] [Related]
37. Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma.
Grossmann P; Gutman DA; Dunn WD; Holder CA; Aerts HJ
BMC Cancer; 2016 Aug; 16():611. PubMed ID: 27502180
[TBL] [Abstract][Full Text] [Related]
38. In vivo molecular profiling of human glioma using diffusion kurtosis imaging.
Hempel JM; Bisdas S; Schittenhelm J; Brendle C; Bender B; Wassmann H; Skardelly M; Tabatabai G; Vega SC; Ernemann U; Klose U
J Neurooncol; 2017 Jan; 131(1):93-101. PubMed ID: 27604789
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of PET probe O
Koyama H; Ikenuma H; Toda H; Kondo G; Hirano M; Kato M; Abe J; Yamada T; Wakabayashi T; Ito K; Natsume A; Suzuki M
Bioorg Med Chem Lett; 2017 May; 27(9):1892-1896. PubMed ID: 28363750
[TBL] [Abstract][Full Text] [Related]
40. Assessment of bevacizumab resistance increased by expression of BCAT1 in IDH1 wild-type glioblastoma: application of DSC perfusion MR imaging.
Cho HR; Hong B; Kim H; Park CK; Park SH; Park S; Choi SH
Oncotarget; 2016 Oct; 7(43):69606-69615. PubMed ID: 27626306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
